pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
PSV-359
Solid Tumor
$CATXPerspective Therapeutics, Inc.
0 catalysts
Phase 2
PTT-936
Solid Tumor
Pyrotech (Beijing) Biotechnology Co Ltd
0 catalysts
Phase 2
PTX-100
Cutaneous T-Cell Lymphoma
Prescient Therapeutics Ltd
0 catalysts
Preclinical
PTX-252
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
← prev
page 31 of 62
next →
131
Pain89
Neurology1
Pleco Therapeutics BV
0 catalysts
Phase 2
PTX-9908
Hepatocellular Carcinoma
C-X-C chemokine receptor type 4
Pertinax Therapeutics Inc
0 catalysts
Preclinical
PV-001
Glioblastoma Multiforme (GBM)
Primevax Immuno Oncology Inc
0 catalysts
Phase 2
PVX-7
Human Papillomavirus (HPV) Associated Cancer
PapiVax Biotech Inc
0 catalysts
Preclinical
Peptide for Glioma
Malignant Glioma
University Hospital Basel
0 catalysts
Phase 1
Peptide to Inhibit CD200 for Oncology
Recurrent Glioblastoma Multiforme (GBM)
OX2 Therapeutics Inc
0 catalysts
Phase 1
Photobac
Recurrent Glioblastoma Multiforme (GBM)
Photolitec LLC
0 catalysts
Phase 2
PolyPEPI-1018
Metastatic Colorectal Cancer
Treos Bio Ltd
0 catalysts
Preclinical
Protexi
Sarcomas
Celloram Inc
0 catalysts
Phase 2
QBS-10072S
Glioblastoma Multiforme (GBM)
Quadriga BioSciences Inc
0 catalysts
Phase 1
QN-302
Metastatic Colorectal Cancer
$AIXCAIxCrypto Holdings, Inc.
0 catalysts
Phase 1
QTX-3034
Colorectal Cancer
Quanta Therapeutics Inc
0 catalysts
Phase 1
QTX-3544
Solid Tumor
Quanta Therapeutics Inc
0 catalysts
Phase 1
QXL-138AM
Gastrointestinal Tract Cancer
Nammi Therapeutics Inc
0 catalysts
Phase 2
R-289
Myelodysplastic Syndrome (Preleukemia)
$RIGLRIGEL PHARMACEUTICALS INC
0 catalysts
Phase 1
R-5780
Basal Cell Carcinoma (Basal Cell Epithelioma)
Rise Therapeutics LLC
0 catalysts
Preclinical
RAD-302
Pancreatic Ductal Adenocarcinoma
$RADXRadiopharm Theranostics Ltd
0 catalysts
Phase 2
RAPA-201
Refractory Multiple Myeloma
Rapa Therapeutics LLC
0 catalysts
Phase 2
RB-601
Head And Neck Cancer
Radiance Biopharma Inc
0 catalysts
Phase 2
RD-1302
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Imviva Biotech
0 catalysts
Phase 2
REC-1245
Lymphoma
$RXRXRECURSION PHARMACEUTICALS, INC.
0 catalysts
Phase 1
REC-4539
Gastric Cancer
$RXRXRECURSION PHARMACEUTICALS, INC.
0 catalysts
Phase 2
REM-422
Adenoid Cystic Carcinoma (ACC)
Remix Therapeutics Inc
0 catalysts
Phase 1
RG-6538
Refractory Multiple Myeloma
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 1
RG-6540
Diffuse Large B-Cell Lymphoma
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
RG-6596
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
RG-6794
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Genentech Inc
0 catalysts